• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于国立眼科研究所视觉功能问卷-25 开发偏好加权指数。

Development of a preference-based index from the National Eye Institute Visual Function Questionnaire-25.

机构信息

Evidera, Bethesda, Maryland.

Allergan Inc, Irvine, California.

出版信息

JAMA Ophthalmol. 2014 Mar;132(3):310-8. doi: 10.1001/jamaophthalmol.2013.7639.

DOI:10.1001/jamaophthalmol.2013.7639
PMID:24435696
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4357476/
Abstract

IMPORTANCE

Understanding how individuals value health states is central to patient-centered care and to health policy decision making. Generic preference-based measures of health may not effectively capture the impact of ocular diseases. Recently, 6 items from the National Eye Institute Visual Function Questionnaire-25 were used to develop the Visual Function Questionnaire-Utility Index health state classification, which defines visual function health states.

OBJECTIVE

To describe elicitation of preferences for health states generated from the Visual Function Questionnaire-Utility Index health state classification and development of an algorithm to estimate health preference scores for any health state.

DESIGN, SETTING, AND PARTICIPANTS: Nonintervention, cross-sectional study of the general community in 4 countries (Australia, Canada, United Kingdom, and United States). A total of 607 adult participants were recruited from local newspaper advertisements. In the United Kingdom, an existing database of participants from previous studies was used for recruitment.

INTERVENTIONS

Eight of 15,625 possible health states from the Visual Function Questionnaire-Utility Index were valued using time trade-off technique.

MAIN OUTCOMES AND MEASURES

A θ severity score was calculated for Visual Function Questionnaire-Utility Index-defined health states using item response theory analysis. Regression models were then used to develop an algorithm to assign health state preference values for all potential health states defined by the Visual Function Questionnaire-Utility Index.

RESULTS

Health state preference values for the 8 states ranged from a mean (SD) of 0.343 (0.395) to 0.956 (0.124). As expected, preference values declined with worsening visual function. Results indicate that the Visual Function Questionnaire-Utility Index describes states that participants view as spanning most of the continuum from full health to dead.

CONCLUSIONS AND RELEVANCE

Visual Function Questionnaire-Utility Index health state classification produces health preference scores that can be estimated in vision-related studies that include the National Eye Institute Visual Function Questionnaire-25. These preference scores may be of value for estimating utilities in economic and health policy analyses.

摘要

重要性

了解个体如何看待健康状况是患者为中心的护理和卫生政策决策的核心。通用的基于偏好的健康衡量标准可能无法有效地捕捉眼部疾病的影响。最近,使用国家眼科研究所视觉功能问卷-25 的 6 个项目来开发视觉功能问卷效用指数健康状况分类,该分类定义了视觉功能健康状况。

目的

描述从视觉功能问卷效用指数健康状况分类中得出的健康状况偏好的启发式方法,并开发一种算法来估算任何健康状况的健康偏好评分。

设计、设置和参与者:在 4 个国家(澳大利亚、加拿大、英国和美国)的一般社区进行的非干预、横断面研究。从当地报纸广告中招募了总共 607 名成年参与者。在英国,利用以前研究的参与者的现有数据库进行招募。

干预措施

使用时间权衡技术对视觉功能问卷效用指数中的 15625 种可能健康状态中的 8 种进行了估值。

主要结果和措施

使用项目反应理论分析为视觉功能问卷效用指数定义的健康状态计算了θ严重程度评分。然后,使用回归模型开发了一种算法,为视觉功能问卷效用指数定义的所有潜在健康状态分配健康状态偏好值。

结果

8 种状态的健康状态偏好值范围从 0.343(0.395)到 0.956(0.124)的平均值(标准差)。如预期的那样,偏好值随着视觉功能的恶化而下降。结果表明,视觉功能问卷效用指数描述了参与者认为从完全健康到死亡的大部分连续体的状态。

结论和相关性

视觉功能问卷效用指数健康状况分类产生的健康偏好评分可在包括国家眼科研究所视觉功能问卷-25 的视力相关研究中进行估计。这些偏好评分在经济和卫生政策分析中的效用估计中可能具有价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6200/4357476/1fbd4753ea76/nihms666969f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6200/4357476/b5d1c8007200/nihms666969f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6200/4357476/1fbd4753ea76/nihms666969f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6200/4357476/b5d1c8007200/nihms666969f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6200/4357476/1fbd4753ea76/nihms666969f2.jpg

相似文献

1
Development of a preference-based index from the National Eye Institute Visual Function Questionnaire-25.基于国立眼科研究所视觉功能问卷-25 开发偏好加权指数。
JAMA Ophthalmol. 2014 Mar;132(3):310-8. doi: 10.1001/jamaophthalmol.2013.7639.
2
Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores.将25项国立眼科研究所视觉功能问卷(NEI VFQ - 25)映射到EQ - 5D效用评分。
Ophthalmic Epidemiol. 2014 Apr;21(2):66-78. doi: 10.3109/09286586.2014.888456. Epub 2014 Feb 25.
3
Rasch analysis in the development of a simplified version of the National Eye Institute Visual-Function Questionnaire-25 for utility estimation.在制定国家眼科研究所视觉功能问卷-25 简化版以进行效用估计的过程中进行 Rasch 分析。
Qual Life Res. 2012 Mar;21(2):323-34. doi: 10.1007/s11136-011-9938-z. Epub 2011 Aug 4.
4
Vision Preference Value Scale and Patient Preferences in Choosing Therapy for Symptomatic Vitreomacular Interface Abnormality.视力偏好值量表和患者对治疗症状性玻璃体黄斑界面异常的治疗方案选择的偏好。
JAMA Ophthalmol. 2018 Jun 1;136(6):658-664. doi: 10.1001/jamaophthalmol.2018.1272.
5
Development of an 18-Item Measure of Symptom Burden in Patients With Glaucoma From the Collaborative Initial Glaucoma Treatment Study's Symptom and Health Problem Checklist.开发一种用于测量青光眼患者症状负担的 18 项工具,该工具源于合作性初始青光眼治疗研究的症状和健康问题清单。
JAMA Ophthalmol. 2017 Dec 1;135(12):1345-1351. doi: 10.1001/jamaophthalmol.2017.4574.
6
Reliability and validity of abbreviated surveys derived from the National Eye Institute Visual Function Questionnaire: the study of osteoporotic fractures.基于国家眼科研究所视觉功能问卷的简表的可靠性和有效性:骨质疏松性骨折研究。
Am J Ophthalmol. 2010 Feb;149(2):330-40. doi: 10.1016/j.ajo.2009.09.008.
7
Psychometric evaluation of the National Eye Institute Visual Function Questionnaire and Visual Function Questionnaire Utility Index in patients with non-infectious intermediate and posterior uveitis.非感染性中后葡萄膜炎患者的国家眼科研究所视觉功能问卷和视觉功能问卷效用指数的心理测量评估。
Qual Life Res. 2013 Dec;22(10):2801-8. doi: 10.1007/s11136-013-0412-y. Epub 2013 May 5.
8
Age-Related Macular Degeneration and Quality of Life in Latinos: The Los Angeles Latino Eye Study.年龄相关性黄斑变性与拉丁裔人群的生活质量:洛杉矶拉丁裔眼研究。
JAMA Ophthalmol. 2016 Jun 1;134(6):683-90. doi: 10.1001/jamaophthalmol.2016.0794.
9
Estimation of a valuation function for a diabetes mellitus-specific preference-based measure of health: the Diabetes Utility Index.估算一个糖尿病特定偏好健康衡量指标的估值函数:糖尿病效用指数。
Pharmacoeconomics. 2010;28(3):201-16. doi: 10.2165/11313990-000000000-00000.
10
Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic Module.尿失禁效用指数的开发:根据尿失禁生活质量问卷和神经源性模块评估与泌尿系统问题相关的基于人群的效用
Health Qual Life Outcomes. 2014 Oct 8;12:147. doi: 10.1186/s12955-014-0147-7.

引用本文的文献

1
Health state utilities associated with X-linked retinitis pigmentosa (XLRP).与X连锁视网膜色素变性(XLRP)相关的健康状态效用值。
Eur J Health Econ. 2025 Mar 17. doi: 10.1007/s10198-025-01761-y.
2
Utility index and vision-related quality of life in patients awaiting specialist eye care.等待专科眼科治疗的患者的效用指数和与视力相关的生活质量。
PLoS One. 2024 Aug 12;19(8):e0307691. doi: 10.1371/journal.pone.0307691. eCollection 2024.
3
A scoping review to create a framework for the steps in developing condition-specific preference-based instruments de novo or from an existing non-preference-based instrument: use of item response theory or Rasch analysis.一项范围综述,旨在为从头开发或从现有非偏好量表中开发特定疾病偏好量表的步骤创建一个框架:使用项目反应理论或 Rasch 分析。
Health Qual Life Outcomes. 2024 May 14;22(1):38. doi: 10.1186/s12955-024-02253-y.
4
Psychometric properties and comparison of four health utility approaches among myopia patients in China.中国近视患者四种健康效用评估方法的心理测量学特性和比较。
Health Qual Life Outcomes. 2023 Jul 4;21(1):66. doi: 10.1186/s12955-023-02150-w.
5
Elicitation of Health State Utility Values in Retinitis Pigmentosa by Time Trade-off in the United Kingdom.英国采用时间权衡法获取视网膜色素变性患者的健康状态效用值
Clinicoecon Outcomes Res. 2023 Jan 15;15:29-39. doi: 10.2147/CEOR.S385094. eCollection 2023.
6
Developing the Breast Utility Instrument to Measure Health-Related Quality-of-Life Preferences in Patients with Breast Cancer: Selecting the Item for Each Dimension.开发乳腺癌效用工具以测量乳腺癌患者与健康相关的生活质量偏好:为每个维度选择项目。
MDM Policy Pract. 2022 Dec 8;7(2):23814683221142267. doi: 10.1177/23814683221142267. eCollection 2022 Jul-Dec.
7
Patient-Reported Health-Related Quality of Life in Individuals with Inherited Retinal Diseases.遗传性视网膜疾病患者报告的健康相关生活质量
Ophthalmol Sci. 2021 Dec 23;2(1):100106. doi: 10.1016/j.xops.2021.100106. eCollection 2022 Mar.
8
Exploring Vision-Related Quality of Life: A Qualitative Study Comparing Patients' Experience of Cataract Surgery with a Standard Monofocal IOL and an Enhanced Monofocal IOL.探索与视力相关的生活质量:一项定性研究,比较患者接受标准单焦点人工晶状体和增强型单焦点人工晶状体白内障手术的体验。
Clin Ophthalmol. 2022 May 27;16:1641-1652. doi: 10.2147/OPTH.S358386. eCollection 2022.
9
Challenges of Cost-Effectiveness Analyses of Novel Therapeutics for Inherited Retinal Diseases.新型遗传性视网膜疾病治疗药物的成本效益分析面临的挑战。
Am J Ophthalmol. 2022 Mar;235:90-97. doi: 10.1016/j.ajo.2021.08.009. Epub 2021 Aug 22.
10
The Utility of Economic Measures to Quantify the Burden of Tinnitus in Affected Individuals: A Scoping Review.经济措施在量化耳鸣患者负担中的作用:一项范围综述
Pharmacoecon Open. 2022 Jan;6(1):21-32. doi: 10.1007/s41669-021-00273-8. Epub 2021 Jul 2.

本文引用的文献

1
Normative comparison of patient-reported outcomes in patients with noninfectious uveitis.非感染性葡萄膜炎患者报告结局的规范比较。
JAMA Ophthalmol. 2013 Feb;131(2):219-25. doi: 10.1001/2013.jamaophthalmol.102.
2
Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).开发和测试从特定疾病测量指标(和其他基于患者的结果测量指标)中推导出基于偏好的健康测量指标的方法。
Health Technol Assess. 2012 Jul;16(32):1-114. doi: 10.3310/hta16320.
3
Agreement about identifying patients who change over time: cautionary results in cataract and heart failure patients.关于识别随时间变化的患者的一致性:白内障和心力衰竭患者的警示结果。
Med Decis Making. 2012 Mar-Apr;32(2):273-86. doi: 10.1177/0272989X11418671. Epub 2011 Oct 18.
4
Deriving a preference-based measure for cancer using the EORTC QLQ-C30.采用 EORTC QLQ-C30 推导癌症偏好测量指标。
Value Health. 2011 Jul-Aug;14(5):721-31. doi: 10.1016/j.jval.2011.01.004.
5
Rasch analysis in the development of a simplified version of the National Eye Institute Visual-Function Questionnaire-25 for utility estimation.在制定国家眼科研究所视觉功能问卷-25 简化版以进行效用估计的过程中进行 Rasch 分析。
Qual Life Res. 2012 Mar;21(2):323-34. doi: 10.1007/s11136-011-9938-z. Epub 2011 Aug 4.
6
Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.地塞米松玻璃体内植入物用于非感染性中间葡萄膜炎或后葡萄膜炎。
Arch Ophthalmol. 2011 May;129(5):545-53. doi: 10.1001/archophthalmol.2010.339. Epub 2011 Jan 10.
7
Estimating a preference-based index for a 5-dimensional health state classification for asthma derived from the asthma quality of life questionnaire.从哮喘生活质量问卷中估计哮喘的 5 维健康状态分类的偏好基础指数。
Med Decis Making. 2011 Mar-Apr;31(2):281-91. doi: 10.1177/0272989X10379646. Epub 2010 Oct 5.
8
Converting condition-specific measures into preference-based outcomes for use in economic evaluation.将特定疾病的衡量指标转换为偏好加权结果,用于经济评估。
Expert Rev Pharmacoecon Outcomes Res. 2008 Oct;8(5):453-61. doi: 10.1586/14737167.8.5.453.
9
Developing preference-based health measures: using Rasch analysis to generate health state values.制定基于偏好的健康测量方法:运用 Rasch 分析生成健康状态值。
Qual Life Res. 2010 Aug;19(6):907-17. doi: 10.1007/s11136-010-9646-0. Epub 2010 May 8.
10
A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures.对基于非偏好的健康衡量指标与通用偏好为基础的衡量指标进行映射(或交叉比对)的研究综述。
Eur J Health Econ. 2010 Apr;11(2):215-25. doi: 10.1007/s10198-009-0168-z. Epub 2009 Jul 8.